uu.seUppsala University Publications
Change search
ReferencesLink to record
Permanent link

Direct link
Suppression of pain and joint destruction by inhibition of the proteasome system in experimental osteoarthritis
Show others and affiliations
2012 (English)In: Pain, ISSN 0304-3959, E-ISSN 1872-6623, Vol. 153, no 1, 18-26 p.Article in journal (Refereed) Published
Abstract [en]

Osteoarthritis is a degenerative joint disease with pain and loss of joint function as major pathological features. Recent studies show that proteasome inhibitors reduce pain in various pathological conditions. We evaluated the effects of MG132, a reversible proteasome inhibitor on pain and joint destruction in a rat model of osteoarthritis. Osteoarthritis was induced by intraarticular injection of monosodium iodoacetate into the rat knee. Knee joint stiffness was scored and nociception was evaluated by mechanical pressure applied to the respective hind paw. Knee joint destruction was assessed by radiological and histological analyses. Expression of matrix metalloproteinase-3 (MMP-3) was analyzed by quantitative reverse transcription polymerase chain reaction in the knee articular cartilage. Expression of substance P (SP) and calcitonin gene-related peptide (CGRP) was studied in the dorsal root ganglia (L4–L6) by quantitative reverse transcription polymerase chain reaction and in the knee joints by immunohistochemistry. Our results indicate that daily treatment of osteoarthritic rats with MG132 significantly increases their mobility while the swelling, pain thresholds, and pathological features of the affected joints were reduced. Furthermore, the upregulated expression of MMP-3, SP, and CGRP in the arthritic rats was normalized by MG132 administration. We conclude that the proteasome inhibitor MG132 reduces pain and joint destruction, probably by involving the peripheral nervous system, and that changes in SP and CGRP expression correlate with alterations in behavioural responses. Our findings suggest that nontoxic proteasome inhibitors may represent a novel pharmacotherapy for osteoarthritis.

Place, publisher, year, edition, pages
2012. Vol. 153, no 1, 18-26 p.
Keyword [en]
Pain, Osteoarthritis, Neuropeptides, Proteasome inhibitor
National Category
Biochemistry and Molecular Biology
URN: urn:nbn:se:uu:diva-166248DOI: 10.1016/j.pain.2011.08.001ISI: 000298368400008PubMedID: 22018973OAI: oai:DiVA.org:uu-166248DiVA: diva2:475761
Available from: 2012-01-11 Created: 2012-01-11 Last updated: 2012-01-25Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Bakalkin, Georgy
By organisation
Department of Pharmaceutical Biosciences
In the same journal
Biochemistry and Molecular Biology

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 366 hits
ReferencesLink to record
Permanent link

Direct link